The Medical Letter on Drugs and Therapeutics
Aspirin for Primary Prevention of Cardiovascular Disease (Revisited)
July 3, 2006 (Issue: 1238)When the use of aspirin for primary prevention of cardiovascular diseases was last reviewed in The Medical Letter, only one placebo-controlled prospective trial was available: the (male) Physicians' Health Study. Last year, a second large,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.